Federico Martinón-Torres

TL;DR: The study suggests that host genetic variation in these regulators of complement activation plays a role in determining the occurrence of invasive disease versus asymptomatic colonization by this pathogen.

TL;DR: This study provides preliminary data regarding test accuracy of a 2-transcript host RNA signature discriminating bacterial from viral infection in febrile children.

TL;DR: The limitations of RSV LRTI management, the drugs in development, and the remaining challenges related to study design, regulatory approval, and implementation are outlined.

TL;DR: RSV F protein nanoparticle vaccination in pregnant women did not meet the prespecified success criterion for efficacy against RSV-associated, medically significant lower respiratory tract infection in infants up to 90 days of life, and the suggestion of a possible benefit with respect to other end-point events involving RSv-associated respiratory disease in infants warrants further study.

TL;DR: This is the first study to use original-source, high-quality surveillance data to establish a global, robust, and homogeneous report on global country-specific RSV seasonality.